Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China at the end of 2019 causing a large global outbreak. As treatments are of the utmost importance, drug repurposing embodies a rich and rapid drug discovery landscape, where candidate drug compounds coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquereau, Sébastien, Nehme, Zeina, Haidar Ahmad, Sandy, Daouad, Fadoua, Van Assche, Jeanne, Wallet, Clémentine, Schwartz, Christian, Rohr, Olivier, Morot-Bizot, Stéphanie, Herbein, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926471/
https://www.ncbi.nlm.nih.gov/pubmed/33672333
http://dx.doi.org/10.3390/v13020354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926471/
https://www.ncbi.nlm.nih.gov/pubmed/33672333
http://dx.doi.org/10.3390/v13020354

Ejemplares similares